A World-first in 3D Medical Imaging
Engineers and scanner Simon Cherry (left) and Ramsey Badawi with a mockup of the EXPLORER total-body scanner. The new machine combines positron emission tomography (PET) and x-ray computed tomography (CT) to produce images more rapidly than existing scanners, opening new possibilities for clinical use and research. Developed in partnership with United Imaging Healthcare of Shanghai, the first scanner could be installed at UC Davis as early as Spring 2019. (Lisa Howard/UC Davis)
EXPLORER, the world’s first medical imaging scanner that can capture a 3D picture of the whole human body at once, has produced its first scans.
The brainchild of UC Davis scientists Simon Cherry and Ramsey Badawi, EXPLORER is a combined positron emission tomography (PET) and X-ray computed tomography (CT) scanner that can image the entire body at the same time. Because the machine captures radiation far more efficiently than other scanners, EXPLORER can produce an image in as little as 1 second and, over time, produce movies that can track specially tagged drugs as they move around the entire body.
The developers expect the technology will have countless applications, from improving diagnostics to tracking disease progression to researching new drug therapies.
The first images from scans of humans using the new device will be shown at the upcoming Radiological Society of North America meeting, which starts Saturday (Nov. 24) in Chicago. The scanner has been developed in partnership with Shanghai-based United Imaging Healthcare (UIH), which built the system based on its latest technology platform and will eventually manufacture the devices for the broader health care market.
EXPLORER image showing glucose metabolism throughout the entire human body. This is the first time a medical imaging scanner has been able to capture a 3-D image of the entire human body simultaneously.
“While I had imagined what the images would look like for years, nothing prepared me for the incredible detail we could see on that first scan,” said Cherry, distinguished professor in the UC Davis Department of Biomedical Engineering. “While there is still a lot of careful analysis to do, I think we already know that EXPLORER is delivering roughly what we had promised.
Badawi, chief of nuclear medicine at UC Davis Health and vice chair for research in the Department of Radiology, said he was dumbfounded when he saw the first images, which were acquired in collaboration with UIH and the Department of Nuclear Medicine at the Zhongshan Hospital in Shanghai.
“The level of detail was astonishing, especially once we got the reconstruction method a bit more optimized,” he said. “We could see features that you just don’t see on regular PET scans. And the dynamic sequence showing the radiotracer moving around the body in three dimensions over time was, frankly, mind-blowing. There is no other device that can obtain data like this in humans, so this is truly novel.”
Badawi and Cherry first conceptualized a total-body scanner 13 years ago. Their idea was kickstarted in 2011 with a $1.5 million grant from the National Cancer Institute, which allowed them to establish a wide-ranging consortium of researchers and other collaborators. And it got a giant boost in 2015 with a $15.5 million grant from the National Institutes of Health. The funding allowed them to team up with a commercial partner and get the first EXPLORER scanner built.
Movie tracing the delivery and distribution of a radiolabeled sugar (fluorodeoxyglucose) following injection into a leg vein. In the first few seconds following injection it travels to the heart from where it is distributed through the arteries to all the organs of the body. At around 3 minutes, some of the substance is excreted from the kidneys into the bladder. Gradual accumulation of the glucose can be seen in the heart, brain and liver over time. The EXPLORER scanner will allow the delivery, metabolism and excretion of many substances and drugs to be followed in the entire human body in a similar manner. Credits: University of California, Davis, United Imaging Healthcare and Zhongshan Hospital, Shanghai.
Cherry said he expects EXPLORER will have a profound impact on clinical research and patient care because it produces higher-quality diagnostic PET scans than have ever been possible. EXPLORER also scans up to 40 times faster than current PET scans and can produce a diagnostic scan of the whole body in as little as 20 to 30 seconds.
Alternatively, EXPLORER can scan with a radiation dose up to 40 times less than a current PET scan, opening new avenues of research and making it feasible to conduct many repeated studies in an individual, or dramatically reduce the dose in pediatric studies, where controlling cumulative radiation dose is particularly important.
“The tradeoff between image quality, acquisition time and injected radiation dose will vary for different applications, but in all cases, we can scan better, faster or with less radiation dose, or some combination of these,” Cherry said.
For the first time, an imaging scanner will be able to evaluate what is happening in all the organs and tissues of the body simultaneously. For example, it could quantitatively measure blood flow or how the body takes up glucose everywhere in the body. Researchers envision using the scanner to study cancer that has spread beyond a single tumor site, inflammation, infection, immunological or metabolic disorders and many other diseases.
“I don’t think it will be long before we see at a number of EXPLORER systems around the world,” Cherry said. “But that depends on demonstrating the benefits of the system, both clinically and for research. Now, our focus turns to planning the studies that will demonstrate how EXPLORER will benefit our patients and contribute to our knowledge of the whole human body in health and disease.”
This article has been republished from materials provided by UC Davis. Note: material may have been edited for length and content. For further information, please contact the cited source.
Staphylococcus epidermidis is an ubiquitous colonizer of healthy human skin, but it is also a notorious source of serious nosocomial infections. Now, a new machine learning technique will help predict the risk of developing a serious, and possibly life-threatening S. epidermidis infection.READ MORE